ArQule Stock Predictions

NASDAQ Stock Exchange

Open Broker Account

$20.00

+0 (+0%)

At Close: Apr 15, 2020

Currently predicting for Thu, 2 May 2024

ARQL Predictions History

5 years ago
Med.Amine.Mrabbi.83367 predicted that ARQL for 2018-07-10 is going $6.70 (-1.62%)

Rank:

5 years ago
Hazem.A..Maguid.5970 predicted that ARQL for 2018-07-06 is going $2.05 (-69.90%)

Rank:

5 years ago
JS predicted that ARQL for 2018-06-18 is going $4.93 (-1.20%)

5 years ago
pickemall predicted that ARQL for 2018-06-19 is going $4.74 (-5.01%)

Rank:

5 years ago
Ahmad predicted that ARQL for 2018-06-15 is going $5.53 (0.36%)

Rank:

5 years ago
JS predicted that ARQL for 2018-06-13 is going $4.97 (-9.80%)

6 years ago
JS predicted that ARQL for 2018-04-18 is going $3.09 (-1.28%)

6 years ago
Adi predicted that ARQL for 2018-03-19 is going $2.18 (-3.11%)

Rank:

6 years ago
JS predicted that ARQL for 2017-06-05 is going $1.34 (2.68%)

6 years ago
Jon predicted that ARQL for 2017-06-05 is going $1.28 (-1.92%)

About ArQule

ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer and non-small cell lung cancer; Phase II clinical trial for the treatment of mesotheli... ARQL Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

ArQule Stock Predictions

ARQL Predictions History

About ArQule

Golden Star

Top Fintech Company